Jiangsu Sunlant is a medical diagnosis overall solution provider integrating R & D, production, sales and medical testing services of in vitro diagnosis rapid detection products. It is also one of the leading enterprises in chemiluminescence detection of microarray protein chips in China. Over the past decade, the company has participated in a number of national "863" projects, key high-tech projects such as the Ministry of science and technology, the Department of science and technology of Jiangsu Province, the Department of industry and information technology and the national development and Reform Commission, and developed and studied a number of products and scientific research achievements. The products are widely used in health fields such as clinical testing, critical illness, grass-roots medical treatment and epidemic prevention and control.
In October 2020, with the approval of the Ministry of human resources and social security, the establishment of Sunlant postdoctoral research workstation was agreed. The postdoctoral scientific research workstation of the company mainly carries out scientific research activities around the technological innovation in the field of medical devices and medical testing, such as microarray chemiluminescence immunoassay technology platform, electrochemiluminescence technology platform, molecular diagnosis technology platform, chemiluminescence immunoassay instrument technology platform and biological raw material technology platform. Promote enterprise product upgrading through the application of high and new technology.
At present, one postdoctoral in Sunlant biological research workstation has entered the station to work. In the next step, the company also plans to conduct extensive cooperation with domestic well-known universities such as Southeast University, Nanjing Medical University, Lanzhou University and many domestic scientific research institutes, so as to promote the company's scientific and technological progress and the construction of high-level talent team, improve the enterprise's technological innovation ability, accelerate the transformation and industrialization of scientific and technological achievements, and maintain the company's leading technology Contribute to improving the scientific research management level of the company.